{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Safety+Testing&page=10", "query": { "intervention": "Safety Testing", "page": 10 }, "page_size": 10 }, "pagination": { "page": 10, "page_size": 10, "total_count": 1467, "total_pages": 147, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Safety+Testing&page=11&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Safety+Testing&page=9&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T12:30:38.764Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07814495", "title": "A Human Influenza Transmission Study Using Naturally Infected Community Donors", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Influenza Donor Visit", "type": "OTHER" }, { "name": "Influenza Recipient Inpatient Exposures Sessions", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 150, "start_date": "2026-12", "completion_date": "2031-03", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-10-23T12:30:38.764Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07814495" }, { "nct_id": "NCT03942029", "title": "A Drug Interaction Study of LY3154207 in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "LY3154207 Capsule", "type": "DRUG" }, { "name": "LY3154207 Tablet", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Fluconazole Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 36, "start_date": "2019-06-21", "completion_date": "2019-12-28", "has_results": false, "last_update_posted_date": "2020-01-18", "last_synced_at": "2026-10-23T12:30:38.764Z", "location_count": 1, "location_summary": "Daytona Beach, Florida", "locations": [ { "city": "Daytona Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03942029" }, { "nct_id": "NCT02647905", "title": "Evaluation of the Accuracy of an Implanted Glucose Sensor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus" ], "interventions": [ { "name": "Continuous Glucose Monitoring System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Senseonics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2016-01", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2018-06-06", "last_synced_at": "2026-10-23T12:30:38.764Z", "location_count": 9, "location_summary": "Concord, California • Escondido, California • Walnut Creek, California + 5 more", "locations": [ { "city": "Concord", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02647905" }, { "nct_id": "NCT05630794", "title": "Testing for Safety and Colorectal Cancer Preventive Effects of ONC201", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Colorectal Adenomatous Polyp", "Colorectal Carcinoma", "Familial Adenomatous Polyposis", "Multiple Adenomatous Polyps" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Colonoscopy", "type": "PROCEDURE" }, { "name": "Dordaviprone Hydrochloride", "type": "DRUG" }, { "name": "Endoscopic Procedure", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Sigmoidoscopy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2025-10-06", "completion_date": "2029-05-01", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-23T12:30:38.764Z", "location_count": 5, "location_summary": "Ann Arbor, Michigan • St Louis, Missouri • Cleveland, Ohio + 2 more", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT05630794" }, { "nct_id": "NCT02858154", "title": "Comparison of High Flow Nasal Cannula Therapy to Nasal Oxygen as a Treatment for Obstructive Sleep Apnea in Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obstructive Sleep Apnea" ], "interventions": [ { "name": "HFNC", "type": "OTHER" }, { "name": "Low flow oxygen by nasal cannula", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "12 Months", "sex": "ALL", "summary": "1 Day to 12 Months" }, "enrollment_count": 9, "start_date": "2016-02", "completion_date": "2021-07-26", "has_results": true, "last_update_posted_date": "2022-03-15", "last_synced_at": "2026-10-23T12:30:38.764Z", "location_count": 2, "location_summary": "Kansas City, Kansas • Cincinnati, Ohio", "locations": [ { "city": "Kansas City", "state": "Kansas" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02858154" }, { "nct_id": "NCT05731986", "title": "Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Cord Injuries", "Spinal Cord Diseases", "Trauma, Nervous System", "Nervous System Diseases", "Central Nervous System Diseases", "Hypotension", "Orthostatic Hypotension", "Cardiovascular Diseases", "Acute Spinal Cord Injury", "Blood Pressure" ], "interventions": [ { "name": "Orthostatic challenge", "type": "DIAGNOSTIC_TEST" }, { "name": "Biostim-5 transcutaneous spinal stimulation - Mapping", "type": "DEVICE" }, { "name": "Biostim-5 transcutaneous spinal stimulation - \"Optimal\" testing", "type": "DEVICE" }, { "name": "Biostim-5 transcutaneous spinal stimulation - \"Sham\" testing", "type": "DEVICE" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "DEVICE" ], "sponsor": "Kessler Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 12, "start_date": "2023-12-01", "completion_date": "2026-08", "has_results": false, "last_update_posted_date": "2025-09-02", "last_synced_at": "2026-10-23T12:30:38.764Z", "location_count": 1, "location_summary": "West Orange, New Jersey", "locations": [ { "city": "West Orange", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05731986" }, { "nct_id": "NCT03804060", "title": "REperfusion With Cooling in CerebraL Acute IscheMia II", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ischemic Stroke" ], "interventions": [ { "name": "Thermogard XP3", "type": "DEVICE" }, { "name": "Recanalization only", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "ZOLL Circulation, Inc., USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 90, "start_date": "2019-05-23", "completion_date": "2024-05-01", "has_results": false, "last_update_posted_date": "2024-05-16", "last_synced_at": "2026-10-23T12:30:38.764Z", "location_count": 8, "location_summary": "Marietta, Georgia • Honolulu, Hawaii • Chicago, Illinois + 4 more", "locations": [ { "city": "Marietta", "state": "Georgia" }, { "city": "Honolulu", "state": "Hawaii" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03804060" }, { "nct_id": "NCT04372641", "title": "Testing the Safety of CB-5339 in Patients With Cancer", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Aggressive Non-Hodgkin Lymphoma", "Indolent Non-Hodgkin Lymphoma", "Locally Advanced Malignant Solid Neoplasm", "Metastatic Malignant Solid Neoplasm" ], "interventions": [ { "name": "p97 Inhibitor CB-5339 Tosylate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2020-06-18", "completion_date": "2021-07-12", "has_results": false, "last_update_posted_date": "2025-09-17", "last_synced_at": "2026-10-23T12:30:38.764Z", "location_count": 2, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04372641" }, { "nct_id": "NCT03719742", "title": "A Clinical Study to Evaluate the Safety and Efficacy of a Baby Cleanser and a Moisturizer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Sponsor Test Products", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Burt's Bees Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "7 Years", "sex": "ALL", "summary": "6 Months to 7 Years" }, "enrollment_count": 20, "start_date": "2018-09-27", "completion_date": "2019-01-18", "has_results": false, "last_update_posted_date": "2019-04-19", "last_synced_at": "2026-10-23T12:30:38.764Z", "location_count": 1, "location_summary": "Richardson, Texas", "locations": [ { "city": "Richardson", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03719742" }, { "nct_id": "NCT07215273", "title": "Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Invasive Mould Infection" ], "interventions": [ { "name": "EL219", "type": "DRUG" }, { "name": "Active Comparator- IV Antifungal (LAmB or voriconazole)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Elion Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2026-02-13", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-23T12:30:38.764Z", "location_count": 10, "location_summary": "Birmingham, Alabama • Sacramento, California • Augusta, Georgia + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Sacramento", "state": "California" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07215273" } ] }